Item 3.01 Transfer of Listing.
On December 22, 2008, Inverness Medical Innovations, Inc. (the "Company") announced its intention to transfer the listing of its Common Stock and Series B Convertible Perpetual Preferred Stock ("Series B Preferred Stock") from the NYSE Alternext US LLC (formerly the American Stock Exchange) ("Alternext") to the New York Stock Exchange (the "NYSE"), and took definitive action to cause the transfer by filing its listing application with NYSE and informing Alternext of its intention to delist its securities from Alternext. Upon transfer to the NYSE, which is currently expected to occur on or about January 6, 2009, the Company's Common Stock will continue to trade under the symbol, "IMA" and its Series B Preferred Stock will continue to trade under the symbol, "IMA.PR.B". The Company's press release announcing the transfer of its listing is furnished as Exhibit 99.1 hereto.
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits. Exhibit No. Description 99.1 Press Release dated December 22, 2008, entitled "Inverness Medical Innovations Plans Move to NYSE"

---

Table of Contents